158 related articles for article (PubMed ID: 16713541)
1. Is adjuvant 5-FU-based chemoradiotherapy for resectable pancreatic adenocarcinoma beneficial? A meta-analysis of an unanswered question.
Khanna A; Walker GR; Livingstone AS; Arheart KL; Rocha-Lima C; Koniaris LG
J Gastrointest Surg; 2006 May; 10(5):689-97. PubMed ID: 16713541
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant therapy in pancreatic cancer: a critical appraisal.
Oettle H; Neuhaus P
Drugs; 2007; 67(16):2293-310. PubMed ID: 17983252
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group.
Klinkenbijl JH; Jeekel J; Sahmoud T; van Pel R; Couvreur ML; Veenhof CH; Arnaud JP; Gonzalez DG; de Wit LT; Hennipman A; Wils J
Ann Surg; 1999 Dec; 230(6):776-82; discussion 782-4. PubMed ID: 10615932
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial.
Neoptolemos JP; Dunn JA; Stocken DD; Almond J; Link K; Beger H; Bassi C; Falconi M; Pederzoli P; Dervenis C; Fernandez-Cruz L; Lacaine F; Pap A; Spooner D; Kerr DJ; Friess H; Büchler MW;
Lancet; 2001 Nov; 358(9293):1576-85. PubMed ID: 11716884
[TBL] [Abstract][Full Text] [Related]
5. Surgery and multimodal treatments in pancreatic cancer--a review on the basis of future multimodal treatment concepts.
Link KH; Leder G; Formentini A; Fortnagel G; Kornmann M; Schatz M; Beger HG
Gan To Kagaku Ryoho; 1999 Jan; 26(1):10-40. PubMed ID: 9987495
[TBL] [Abstract][Full Text] [Related]
6. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer.
Neoptolemos JP; Stocken DD; Friess H; Bassi C; Dunn JA; Hickey H; Beger H; Fernandez-Cruz L; Dervenis C; Lacaine F; Falconi M; Pederzoli P; Pap A; Spooner D; Kerr DJ; Büchler MW;
N Engl J Med; 2004 Mar; 350(12):1200-10. PubMed ID: 15028824
[TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant or adjuvant therapy for resectable esophageal cancer: a systematic review and meta-analysis.
Malthaner RA; Wong RK; Rumble RB; Zuraw L;
BMC Med; 2004 Sep; 2():35. PubMed ID: 15447788
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant intra-arterial chemotherapy and radiotherapy versus surgery alone in resectable pancreatic and periampullary cancer: a prospective randomized controlled trial.
Morak MJ; van der Gaast A; Incrocci L; van Dekken H; Hermans JJ; Jeekel J; Hop WC; Kazemier G; van Eijck CH
Ann Surg; 2008 Dec; 248(6):1031-41. PubMed ID: 19092348
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant therapy for pancreatic cancer: to treat or not to treat?
Berlin JD
Oncology (Williston Park); 2007 May; 21(6):712-8; discussion 720, 725-6, 730. PubMed ID: 17564327
[TBL] [Abstract][Full Text] [Related]
10. The role of adjuvant chemotherapy for patients with resected pancreatic cancer: systematic review of randomized controlled trials and meta-analysis.
Boeck S; Ankerst DP; Heinemann V
Oncology; 2007; 72(5-6):314-21. PubMed ID: 18187951
[TBL] [Abstract][Full Text] [Related]
11. Thymidylate synthase expression predicts the response to 5-fluorouracil-based adjuvant therapy in pancreatic cancer.
Hu YC; Komorowski RA; Graewin S; Hostetter G; Kallioniemi OP; Pitt HA; Ahrendt SA
Clin Cancer Res; 2003 Sep; 9(11):4165-71. PubMed ID: 14519641
[TBL] [Abstract][Full Text] [Related]
12. Adenocarcinoma of the head of the pancreas: effects of surgical and nonsurgical therapy on survival--a ten-year experience.
Carr JA; Ajlouni M; Wollner I; Wong D; Velanovich V
Am Surg; 1999 Dec; 65(12):1143-9. PubMed ID: 10597062
[TBL] [Abstract][Full Text] [Related]
13. Preoperative capecitabine and concurrent radiation for borderline resectable pancreatic cancer.
Stokes JB; Nolan NJ; Stelow EB; Walters DM; Weiss GR; de Lange EE; Rich TA; Adams RB; Bauer TW
Ann Surg Oncol; 2011 Mar; 18(3):619-27. PubMed ID: 21213060
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant and neoadjuvant therapies in resectable pancreatic cancer: a systematic review of randomized controlled trials.
D'Angelo FA; Antolino L; La Rocca M; Petrucciani N; Magistri P; Aurello P; Ramacciato G
Med Oncol; 2016 Mar; 33(3):28. PubMed ID: 26883935
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant therapy in pancreatic cancer.
Thomas A; Dajani K; Neoptolemos JP; Ghaneh P
Dig Dis; 2010; 28(4-5):684-92. PubMed ID: 21088421
[TBL] [Abstract][Full Text] [Related]
16. Histopathological response to preoperative chemoradiation for resectable pancreatic adenocarcinoma: the French Phase II FFCD 9704-SFRO Trial.
Le Scodan R; Mornex F; Partensky C; Mercier C; Valette PJ; Ychou M; Roy P; Scoazec JY
Am J Clin Oncol; 2008 Dec; 31(6):545-52. PubMed ID: 19060585
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of adjuvant chemoradiation after pancreaticoduodenectomy with mesenterico-portal vein resection for adenocarcinoma of the pancreas.
Hristov B; Reddy S; Lin SH; Cameron JL; Pawlik TM; Hruban RH; Swartz MJ; Edil BH; Kemp C; Wolfgang CL; Herman JM
Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):176-80. PubMed ID: 19394156
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant treatment for resectable pancreatic cancer.
Chua YJ; Cunningham D
J Clin Oncol; 2005 Jul; 23(20):4532-7. PubMed ID: 16002844
[TBL] [Abstract][Full Text] [Related]
19. [The value of chemoradiotherapy in the management of locally advanced pancreatic adenocarcinoma: systematic review].
Azria D; Seblain-El-Guerche C; Girard N; Hennequin C; Huguet F
Bull Cancer; 2008 Nov; 95(11):1116-30. PubMed ID: 19036684
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy for resectable and advanced pancreatic cancer.
Berlin JD; Rothenberg M
Oncology (Williston Park); 2001 Oct; 15(10):1241-9, 1254; discussion 1254-64. PubMed ID: 11702956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
